Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 17 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  2. US 9266960

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  3. US 9254316

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

  4. US 9220735

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    AKER BIOMARINE ANTARCTIC AS · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  5. US 9221840

    Treating protein folding disorders with small molecule CFTR correctors

    DISCOVERYBIOMED, INC. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  6. US 9216214

    Replication-competent adenoviral vectors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  7. US 9212212

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  8. US 9205276

    Light as a replacement for mitogenic factors on progenitor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND SERVICES · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  9. US 9200075

    Nucleic acids encoding antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  10. US 9198959

    Adenovirus vaccine vector and methods of use

    Regents of the University of Minnesota · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  11. US 9193769

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  12. US 9169509

    Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity

    The Board of Regents of the University of Texas System · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  13. US 9161969

    Protection against influenza infection by granulocyte-macrophage colony stimulating factor

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  14. US 9163248

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  15. US 9155798

    Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents

    Regents of the University of Minnesota · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  16. US 9150644

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  17. US 9145552

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  18. US 9144557

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  19. US 9133259

    Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof

    The Regents of the University of California · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  20. US 9127056

    Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  21. US 9120853

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  22. US 9114116

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Northwestern University · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  23. US 9085604

    Antiproliferative factor and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  24. US 9062310

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.